It is time to include real-world effectiveness data on medicinal product labels

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(22)00003-0 ◽

2022 ◽

Author(s):

Rafael Dal-Ré ◽

Raphaël Porcher ◽

Frits R Rosendaal ◽

Brigitte Schwarzer-Daum

Keyword(s):

Medicinal Product ◽

Effectiveness Data

Download Full-text

Real World Comparative Effectiveness data of Natalizumab vs Fingolimod for the treatment of Relapsing-Remitting Multiple Sclerosis: Results from a Systematic Literature Review

10.26226/morressier.59a3edabd462b8028d8951ff ◽

2017 ◽

Author(s):

Carlos Acosta

Keyword(s):

Multiple Sclerosis ◽

Literature Review ◽

Systematic Literature Review ◽

Comparative Effectiveness ◽

Relapsing Remitting ◽

Remitting Multiple Sclerosis ◽

Relapsing Remitting Multiple Sclerosis ◽

Effectiveness Data

Download Full-text

PNS136 Use of Real-World Evidence in Advanced Therapy Medicinal Product (ATMP) HTA Decisions

Value in Health ◽

10.1016/j.jval.2020.08.1580 ◽

2020 ◽

Vol 23 ◽

pp. S663

Author(s):

C. Watson ◽

G. Jones ◽

R. Miller

Keyword(s):

Medicinal Product ◽

Advanced Therapy Medicinal Product ◽

Real World Evidence ◽

Advanced Therapy

Download Full-text

Statin Cost-Effectiveness Comparisons Using Real-World Effectiveness Data: Formulary Implications

Value in Health ◽

10.1111/j.1524-4733.2008.00354.x ◽

2008 ◽

Vol 11 (7) ◽

pp. 1061-1069 ◽

Author(s):

Robert L. Ohsfeldt ◽

Sanjay K. Gandhi ◽

Kathleen M. Fox ◽

James M. McKenney

Keyword(s):

Cost Effectiveness ◽

Effectiveness Data

Download Full-text

PTH-081 Ustekinumab treatment strategies in refractory Crohn’s Disease: Real-world effectiveness data from a UK IBD centre

10.1136/gutjnl-2019-bsgabstracts.140 ◽

2019 ◽

Author(s):

Richard Harris ◽

Martin McDonnell ◽

Marion Bettey ◽

Louise Downey ◽

David Young ◽

...

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Treatment Strategies ◽

Effectiveness Data

Download Full-text

The use (or rather the non-use) of cost-effectiveness data in priority setting decisions – are we underestimating the barriers to using health economics in real world priority setting decisions? Comment on "Use of cost-effectiveness data in priority setting decisions: experiences from the national guidelines for heart diseases in Sweden"

International Journal of Health Policy and Management ◽

10.15171/ijhpm.2015.28 ◽

2015 ◽

Vol 4 (3) ◽

pp. 181-183

Author(s):

Sandra T. Erntoft

Keyword(s):

Cost Effectiveness ◽

Health Economics ◽

Priority Setting ◽

Heart Diseases ◽

National Guidelines ◽

Effectiveness Data

Download Full-text

Risedronate clinical efficacy and bisphosphonate new effectiveness data from real world clinical practice

Bone ◽

10.1016/j.bone.2009.07.045 ◽

2009 ◽

Vol 45 ◽

pp. S132-S133

Author(s):

T. Thomas

Keyword(s):

Clinical Practice ◽

Clinical Efficacy ◽

Effectiveness Data

Download Full-text

Why Does Primary Angioplasty Not Work in Registries? Quantifying the Susceptibility of Real-World Comparative Effectiveness Data to Allocation Bias

Circulation Cardiovascular Quality and Outcomes ◽

10.1161/circoutcomes.112.966853 ◽

2012 ◽

Vol 5 (6) ◽

pp. 759-766 ◽

Author(s):

Sayan Sen ◽

Justin E. Davies ◽

Iqbal S. Malik ◽

Rodney A. Foale ◽

Ghada W. Mikhail ◽

...

Keyword(s):

Comparative Effectiveness ◽

Primary Angioplasty ◽

Effectiveness Data

Download Full-text

Evaluating Mental Health Services; How Do Programs for Children “Work” in the Real World? Edited by Carol T. Nixon & Denine A. Northrup. Sage, Thousand Oaks CA, 1997. pp. 306. £16.60 (pb).

Journal of Child Psychology and Psychiatry ◽

10.1017/s0021963098222918 ◽

1998 ◽

Vol 39 (6) ◽

pp. 935-936

Author(s):

Anne Worrall-Davies

Keyword(s):

Mental Health ◽

Mental Health Services ◽

Health Services ◽

Download Full-text

Replications can cause distorted belief in scientific progress

Behavioral and Brain Sciences ◽

10.1017/s0140525x18000584 ◽

2018 ◽

Vol 41 ◽

Author(s):

Michał Białek

Keyword(s):

Scientific Progress ◽

Psychological Science

AbstractIf we want psychological science to have a meaningful real-world impact, it has to be trusted by the public. Scientific progress is noisy; accordingly, replications sometimes fail even for true findings. We need to communicate the acceptability of uncertainty to the public and our peers, to prevent psychology from being perceived as having nothing to say about reality.

Download Full-text

Current Issues: Evidence-Based Practice for the Real World: Thoughts on Clinical Education in Communication Disorders

Perspectives on Administration and Supervision ◽

10.1044/aas20.3.100 ◽

2010 ◽

Vol 20 (3) ◽

pp. 100-105 ◽

Author(s):

Anne K. Bothe

Keyword(s):

Clinical Education ◽

Evidence Based Practice ◽

Communication Disorders ◽

University Faculty ◽

Evidence Based ◽

Speech Language Pathology ◽

Basic Principles ◽

The Real ◽

Language Pathology

This article presents some streamlined and intentionally oversimplified ideas about educating future communication disorders professionals to use some of the most basic principles of evidence-based practice. Working from a popular five-step approach, modifications are suggested that may make the ideas more accessible, and therefore more useful, for university faculty, other supervisors, and future professionals in speech-language pathology, audiology, and related fields.

Download Full-text